Detection of integron-associated gene cassettes and other antimicrobial resistance genes in enterotoxigenic Bacteroides fragilis.

[1]  M. Anjum,et al.  Antibiotic resistance gene profiling of faecal and oral anaerobes collected during an antibiotic challenge trial. , 2013, Anaerobe.

[2]  E. Hummers-Pradier,et al.  Resistance profiles of urinary tract infections in general practice - an observational study , 2012, BMC Urology.

[3]  L. Martínez-Martínez,et al.  qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. , 2012, The Journal of antimicrobial chemotherapy.

[4]  R. Rennie,et al.  First Comprehensive Evaluation of the M.I.C. Evaluator Device Compared to Etest and CLSI Reference Dilution Methods for Antimicrobial Susceptibility Testing of Clinical Strains of Anaerobes and Other Fastidious Bacterial Species , 2012, Journal of Clinical Microbiology.

[5]  R. Rollet,et al.  First National Survey of Antibiotic Susceptibility of the Bacteroides fragilis Group: Emerging Resistance to Carbapenems in Argentina , 2012, Antimicrobial Agents and Chemotherapy.

[6]  J. Karlowsky,et al.  Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study , 2011, Antimicrobial Agents and Chemotherapy.

[7]  M. Karczmarczyk,et al.  Molecular Characterization of Multidrug-Resistant Escherichia coli Isolates from Irish Cattle Farms , 2011, Applied and Environmental Microbiology.

[8]  S. Yamasaki,et al.  QRDR mutations, efflux system & antimicrobial resistance genes in enterotoxigenic Escherichia coli isolated from an outbreak of diarrhoea in Ahmedabad, India , 2011, The Indian journal of medical research.

[9]  E. Pamer,et al.  Regulation of innate and adaptive immunity by the commensal microbiota. , 2011, Current opinion in immunology.

[10]  H. Wexler,et al.  Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains , 2011, Clinics.

[11]  E. Urbán,et al.  Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  C. Sears,et al.  Bacteroides spp. and diarrhea , 2010, Current opinion in infectious diseases.

[13]  D. Yong,et al.  Antimicrobial Susceptibility Patterns for Recent Clinical Isolates of Anaerobic Bacteria in South Korea , 2010, Antimicrobial Agents and Chemotherapy.

[14]  C. Nord,et al.  Metronidazole is still the drug of choice for treatment of anaerobic infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  H. Dupont,et al.  Microbial Etiology of Travelers' Diarrhea in Mexico, Guatemala, and India: Importance of Enterotoxigenic Bacteroides fragilis and Arcobacter Species , 2010, Journal of Clinical Microbiology.

[16]  A. Carattoli,et al.  Conjugative transferability of the A/C plasmids from Salmonella enterica isolates that possess or lack bla(CMY) in the A/C plasmid backbone. , 2009, Foodborne pathogens and disease.

[17]  D. Yong,et al.  Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea. , 2009, The Korean journal of laboratory medicine.

[18]  C. Sears.  Enterotoxigenic Bacteroides fragilis: a Rogue among Symbiotes , 2009, Clinical Microbiology Reviews.

[19]  G. Jacoby,et al.  Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period , 2008, Antimicrobial Agents and Chemotherapy.

[20]  F. Aarestrup,et al.  qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin , 2008, Antimicrobial Agents and Chemotherapy.

[21]  A. Quesada,et al.  Genetic determinants for cfxA expression in Bacteroides strains isolated from human infections. , 2008, The Journal of antimicrobial chemotherapy.

[22]  A. Weintraub,et al.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Hannah M. Wexler,et al.  Bacteroides: the Good, the Bad, and the Nitty-Gritty , 2007, Clinical Microbiology Reviews.

[24]  A. Robicsek,et al.  Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme , 2006, Antimicrobial Agents and Chemotherapy.

[25]  Amit Ghosh,et al.  Mechanism of Drug Resistance in Clonally Related Clinical Isolates of Vibrio fluvialis Isolated in Kolkata, India , 2006, Antimicrobial Agents and Chemotherapy.

[26]  J. Harel,et al.  Antimicrobial Resistance Genes in Enterotoxigenic Escherichia coli O149:K91 Isolates Obtained over a 23-Year Period from Pigs , 2003, Antimicrobial Agents and Chemotherapy.

[27]  Amita,et al.  Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India , 2002, Antimicrobial Agents and Chemotherapy.

[28]  P. H. Roy,et al.  IntI2 Integron Integrase in Tn7 , 2002, Journal of bacteriology.

[29]  D. Mazel,et al.  Integrons: natural tools for bacterial genome evolution. , 2001, Current opinion in microbiology.

[30]  P. White,et al.  Integrons and Gene Cassettes in theEnterobacteriaceae , 2001, Antimicrobial Agents and Chemotherapy.

[31]  H. Oh,et al.  gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains , 2001, Antimicrobial Agents and Chemotherapy.

[32]  A. Carattoli.  Importance of integrons in the diffusion of resistance. , 2001, Veterinary research.

[33]  D. Hooper.  Emerging mechanisms of fluoroquinolone resistance. , 2001, Emerging infectious diseases.

[34]  E. R. Rocha,et al.  Analysis of cepA and other Bacteroides fragilis genes reveals a unique promoter structure. , 2000, FEMS microbiology letters.

[35]  L. Lobo,et al.  Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene? , 2000, The Journal of antimicrobial chemotherapy.

[36]  P. Tulkens,et al.  Aminoglycosides: Activity and Resistance , 1999, Antimicrobial Agents and Chemotherapy.

[37]  U. Mitra,et al.  Association of enterotoxigenic Bacteroides fragilis with childhood diarrhoea. , 1997, The Indian journal of medical research.

[38]  S. Trinh,et al.  Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp , 1996, Journal of clinical microbiology.

[39]  J. Rosenblatt,et al.  Evaluation of the Etest for susceptibility testing of anaerobic bacteria. , 1995, Diagnostic microbiology and infectious disease.

[40]  E. Goldstein,et al.  Evaluation of the E test for susceptibility testing of anaerobic bacteria , 1991, Journal of clinical microbiology.

[41]  S. T. Liu,et al.  Rapid procedure for detection and isolation of large and small plasmids , 1981, Journal of bacteriology.

[42]  A. Parija.  A clinical study of trimethoprim and sulphamethoxazole (Septran) in the treatment of bacterial diarrhoeas , 1975, Indian journal of pediatrics.

[43]  J. Rosenblatt,et al.  Lack of Activity of Sulfamethoxazole and Trimethoprim Against Anaerobic Bacteria , 1974, Antimicrobial Agents and Chemotherapy.

[44]  A. Sawicka-Grzelak,et al.  [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes]. , 2001, Medycyna doswiadczalna i mikrobiologia.

[45]  D. Citron,et al.  Wadsworth Anaerobic Bacteriology Manual , 1980 .